Cargando…

Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is common in the German population, with an even higher prevalence in inflammatory bowel disease patients. AIM: To investigate the risk factors for NAFLD in inflammatory bowel disease patients. METHODS: This monocentric retrospective study with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann, Peter, Jung, Victoria, Behnisch, Rouven, Gauss, Annika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739163/ https://www.ncbi.nlm.nih.gov/pubmed/33362390 http://dx.doi.org/10.3748/wjg.v26.i46.7367

Ejemplares similares

Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases
por: Hoffmann, Peter, et al.
Publicado: (2020)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
por: Michalak, Agata, et al.
Publicado: (2020)

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016)

Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
por: Bertol, Franciele Sabadin, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
por: Gordon, Benjamin Langan, et al.
Publicado: (2022)

Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
por: Delicce, Michael, et al.
Publicado: (2022)

Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease
por: Hoffmann, Peter, et al.
Publicado: (2019)

Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States
por: Alkhouri, Naim, et al.
Publicado: (2022)

Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
por: Choi, Catherine J, et al.
Publicado: (2020)

Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil
por: Martins, Adalberta Lima, et al.
Publicado: (2022)

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
por: Halling, Morten L, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
por: Jiang, Yi, et al.
Publicado: (2021)

Role of telomere shortening in anticipation of inflammatory bowel disease
por: Truta, Brindusa, et al.
Publicado: (2020)

Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
por: Bajer, Lukas, et al.
Publicado: (2018)

Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease
por: Ma, Hai-Qin, et al.
Publicado: (2018)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified
por: Monteiro, Sara, et al.
Publicado: (2017)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
por: Horvat, Natally, et al.
Publicado: (2016)

Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease
por: Bengi, Göksel, et al.
Publicado: (2018)

Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis
por: Haider, Maryam Bilal, et al.
Publicado: (2023)

Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases
por: Su, Wen, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients
por: Girardin, Marc, et al.
Publicado: (2018)

Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
por: Berkowitz, Joshua C, et al.
Publicado: (2018)

Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023)

Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2019)

Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
por: Lee, Jooyoung, et al.
Publicado: (2019)

Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective
por: Pallav, Kumar, et al.
Publicado: (2017)

Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease
por: Ehrenpreis, Eli D, et al.
Publicado: (2017)

Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population
por: Kichloo, Asim, et al.
Publicado: (2021)

Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene
por: Ohya, Takashi, et al.
Publicado: (2017)

Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States
por: Soni, Aakriti, et al.
Publicado: (2023)

Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
por: Yuan, Xian-Xian, et al.
Publicado: (2019)

Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?
por: Forlano, Roberta, et al.
Publicado: (2021)

Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: A new challenge on the horizon in the United States
por: Dahiya, Dushyant Singh, et al.
Publicado: (2023)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017)

Serological investigation of IgG and IgE antibodies against food antigens in patients with inflammatory bowel disease
por: Wang, Hai-Yang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4bvv844g14ng67n1n4vtmra9i9